Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE): study protocol for a randomized controlled trial

BACKGROUND: Onset of systemic lupus erythematosus (SLE) is preceded by a preclinical phase characterized by expression of autoantibodies and nonspecific clinical symptoms. Hydroxychloroquine is a treatment for lupus that is widely used based on longstanding experience and a very good safety profile....

Descripción completa

Detalles Bibliográficos
Autores principales: Olsen, Nancy J., James, Judith A., Arriens, Cristina, Ishimori, Mariko L., Wallace, Daniel J., Kamen, Diane L., Chong, Benjamin F., Liao, Duanping, Chinchilli, Vernon M., Karp, David R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302430/
https://www.ncbi.nlm.nih.gov/pubmed/30572906
http://dx.doi.org/10.1186/s13063-018-3076-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302430/
https://www.ncbi.nlm.nih.gov/pubmed/30572906
http://dx.doi.org/10.1186/s13063-018-3076-7

Ejemplares similares